Market cap
$7 Mln
Revenue (TTM)
$4 Mln
P/E Ratio
--
P/B Ratio
2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -11.80 | -23.81 | -23.15 | -13.38 |
| EBIT | -- | -11.74 | 14.30 | 12.35 | 5.88 |
| Net Profit | -- | -12.81 | 13.94 | 12.21 | 5.86 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | May-25 | May-24 |
| EBIT-Margin
| -112.01 | -92.66 | -96.00 | -93.62 | -109.62 |
| Net Margin
| -- | -102.48 | -96.49 | -- | -- |
| Return on equity
| -76.50 | -68.93 | -98.54 | -92.99 | -65.28 |
| Return on Capital
| -68.66 | -61.11 | -- | -83.31 | -59.24 |
| Return on Assets
| -57.05 | -52.29 | -53.98 | -65.44 | -50.43 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.11 | 0.12 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
--
|
-83.31
|
-59.24
|
-63.44
|
-44.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-98.54
Lower than Peers by 103.48
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
-98.54
|
-92.99
|
-65.28
|
-71.23
|
-51.63
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
ROA
-53.98
Lower than Peers by 56.44
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
-53.98
|
-65.44
|
-50.43
|
-55.29
|
-39.07
|
|
Peer Median
|
2.45
|
--
|
--
|
--
|
--
|
EBIT Margin
-96.00
Lower than Peers by 104.47
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
-96.00
|
-93.62
|
-109.62
|
-132.78
|
-24.02
|
|
Peer Median
|
8.47
|
--
|
--
|
--
|
--
|
Net Margin
-96.49
Lower than Peers by 101.16
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
-96.49
|
-93.64
|
-110.40
|
-133.73
|
-24.01
|
|
Peer Median
|
4.68
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-23.81
Lower than Peers by 32.30
Year on year growth in net sales
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
-23.81
|
-0.02
|
0.01
|
-0.72
|
1.62
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
EBIT Growth
14.30
Higher than Peers by 3.65
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
14.30
|
16.24
|
16.26
|
-56.36
|
39.01
|
|
Peer Median
|
10.65
|
--
|
--
|
--
|
--
|
Net Profit Growth
13.94
Higher than Peers by 0.39
Year on year growth in profit after tax
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
13.94
|
16.81
|
16.27
|
-57.58
|
39.15
|
|
Peer Median
|
13.55
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
--
|
0.11
|
0.12
|
0.09
|
0.17
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.06
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
0.06
|
0.09
|
0.05
|
0.03
|
0.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.64
Lower than Peers by 0.18
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
2.64
|
2.80
|
3.51
|
6.58
|
4.69
|
|
Peer Median
|
2.83
|
--
|
--
|
--
|
--
|
Quick Ratio
1.59
Lower than Peers by 0.46
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
1.59
|
1.95
|
2.43
|
5.52
|
3.49
|
|
Peer Median
|
2.05
|
--
|
--
|
--
|
--
|
Interest Coverage
-691.17
Lower than Peers by 696.13
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
-691.17
|
--
|
--
|
--
|
-170.19
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
21.75
Higher than Peers by 5.30
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
21.75
|
13.76
|
17.49
|
13.52
|
4.10
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.56
Higher than Peers by 0.06
Sales / Average Total Assets
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
0.56
|
0.70
|
0.46
|
0.41
|
1.63
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
--
|
57.70
|
56.29
|
51.17
|
21.57
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
--
|
146.69
|
168.48
|
166.91
|
64.60
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
--
|
22.12
|
24.03
|
40.31
|
13.41
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
--
|
182.27
|
200.75
|
177.77
|
72.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
1.96
Lower than Peers by 1.83
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
1.96
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.79
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-5.42
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
-5.42
|
0.42
|
0.61
|
1.28
|
1.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
7
Lower than Peers by 534
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
7
|
--
|
--
|
--
|
--
|
|
Peer Median
|
540
|
--
|
--
|
--
|
--
|